Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Dankzij deze extra werking kan retatrutide effectiever zijn bij hardnekkig vet, zoals orgaanvet, en daarmee mogelijk zorgen voor groter gewichtsverlies dan eerdere medicijnen
Some individuals are naturally more or less sensitive to GLP-1 agonist effects, which translates to varying dose requirements for equivalent responses
Funding No funding was received for this study
Retatrutide Side Effects: What Clinical Trials Show So Far Retatrutide is a triple-receptor agonist (GLP-1, GIP, and glucagon) being developed by Eli Lilly for obesity and type 2 diabetes
US$ 20.29
US$ 24.01
US$ 21.35
